Fig. 1 General schema for using the adoptive cell transfer of naturally occurring autologous TILs. General schema for using the adoptive cell transfer.

Slides:

Advertisements

Similar presentations

Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015.

Advertisements

1 Steven A. Feldman, Ph.D. Surgery Branch, NCI MEASUREMENT CHALLENGES FOR CAR-T BIOMANUFACTURING January 29, 2016 Adoptive Cell Therapy for the Treatment.

Slide 1 Presented By Christian Hinrichs at 2014 ASCO Annual Meeting.

Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system Zhiping Li, Huizhi Lin, Shiqi Yang, Anna.

Hyaluronic acid skin fillers: Adverse reactions and skin testing

Volume 14, Issue 1, Pages (January 2012)

Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.

Program Goals. Program Goals Immunotherapy of B-cell Malignancies.

Volume 19, Issue 12, Pages (December 2011)

Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice by Robert G. Newman,

A Promiscuous Survivin-Derived T-Cell Epitope Restricted to the HLA-A3 Super-Type Alleles Niels Junker, Shamaila Munir, Pia Kvistborg, Per thor Straten,

Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers by Andrea.

Expansion and isolation of NY-ESO-1–specific T cell clones.

Rachael A. Clark, Benjamin F

Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.

Volume 19, Issue 3, Pages (March 2011)

Functional Investigation of Fas Ligand Expressions in Human Non-Small Cell Lung Cancer Cells and Its Clinical Implications Yidan Lin, MD, PhD, Lunxu.

Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells Allan D. Hess,

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen by Laura A. Johnson,

HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,

Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion Marco Donia, Morten Hansen,

Adoptive Cellular Therapy using Cells Enriched for NKG2D+CD3+CD8+T Cells after Autologous Transplantation for Myeloma Kenneth R. Meehan, Laleh Talebian,

Jacob A. Klapper, MD, Jeremy L. Davis, MD, R

Adoptive Therapy with T Cells/NK Cells

Volume 13, Issue 1, Pages (January 2006)

Volume 26, Issue 2, Pages (February 2018)

Volume 23, Issue 8, Pages (August 2015)

HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,

Volume 27, Issue 2, Pages (August 2007)

Neoantigen-specific TCR expansion in stimulated T-cell cultures.

Volume 18, Issue 4, Pages (April 2010)

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,

Molecular Therapy - Methods & Clinical Development

Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells Matthieu Allez, Jens Brimnes, Iris Dotan, Lloyd.

Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.

Volume 120, Issue 2, Pages (February 2001)

Volume 17, Issue 2, Pages (February 2009)

Immunotherapy for Advanced Melanoma

CD8+ T cells were immunomodulated and required for the efficacy of anti–4-1BB/anti–PD-1 combination treatment. CD8+ T cells were immunomodulated and required.

Volume 24, Issue 6, Pages (June 2016)

Interleukin 15 is a potent stimulant of intraepithelial lymphocytes

Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.

Fig. 4. The effect of combined inhibition of BCL-2 and BCR-ABL on leukemia LT-HSC frequency. The effect of combined inhibition of BCL-2 and BCR-ABL on.

Fig. 2 Estimate of the neoantigen repertoire in human cancer.

Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions Richard S. Kalish, MD,

Volume 19, Issue 4, Pages (April 2011)

Fig. 5. Immunohistochemistry of the tumor microenvironment in GBM specimens before and after CART-EGFRvIII infusion. Immunohistochemistry of the tumor.

Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.

Topical imiquimod treatment of a cutaneous melanomametastasis

Fig. 1. Detection of circulating tumor DNA in CRPC patients.

Volume 19, Issue 4, Pages (April 2011)

by Jennifer Couzin-Frankel

Reduced tumor growth in CCR5-deficient mice is associated with perturbed killing ability of Treg cells. Reduced tumor growth in CCR5-deficient mice is.

CARTmeso cell induction of antitumor antibodies.

Efficient and preferential pairing of cysteine-modified TCRs

PTEN expression regulates autophagy in tumor cells, reducing T cell–mediated killing. PTEN expression regulates autophagy in tumor cells, reducing T cell–mediated.

Immune evasion occurs independently of perforin-mediated killing.

Supplementary Figure 1 A B C D r2 = 0.15

Evaluation of clinical responses after infusion of CART19 cells

NKT cell recognition of CD1d1 molecules is inhibited by treatment with ascites. NKT cell recognition of CD1d1 molecules is inhibited by treatment with.

CD4+ cells are required to generate protective immunity against the MT-HA tumor in HA104 mice. CD4+ cells are required to generate protective immunity.

Delineating cancer evolution with single-cell sequencing

Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas

Fig. 1 Cancer exome–based identification of neoantigens.

Fig. 7 BEL immune response.

Memoirs of a Reincarnated T Cell

Meningeal γδ T cell homeostasis is independent of inflammatory signals

Volume 2, Issue 6, Pages (December 2012)

Fig. 5 CD19-tPSMA(N9del) CAR T cell numbers in mouse and human.

Presentation transcript:

Fig. 1 General schema for using the adoptive cell transfer of naturally occurring autologous TILs. General schema for using the adoptive cell transfer of naturally occurring autologous TILs. The resected melanoma specimen is digested into a single-cell suspension or divided into multiple tumor fragments that are individually grown in IL-2. Lymphocytes overgrow, destroy tumors within 2 to 3 weeks, and generate pure cultures of lymphocytes that can be tested for reactivity in coculture assays. Individual cultures are then rapidly expanded in the presence of excess irradiated feeder lymphocytes, OKT3, and IL-2. By approximately 5 to 6 weeks after resecting the tumor, up to 1011 lymphocytes can be obtained for infusion into patients. Steven A. Rosenberg, and Nicholas P. Restifo Science 2015;348:62-68 Copyright © 2015, American Association for the Advancement of Science